Biotech is our opening topic this morning as we deep dive into a double announcement from EQT. The firm is acquiring a Swedish biotech company as part of the launch of a new Healthcare Growth Strategy ...

(RTTNews) - EQT (EQT) introduced the EQT Healthcare Growth Strategy, a dedicated healthcare buyout strategy. The strategy aims to enable the development of medical research, diagnostics, tools and ...

EQT has announced the acquisition of Swedish biotech company Mabtech in what partner Isabel de Paoli told PE Hub Europe was a “perfect fit” for the private equity firm’s new Healthcare Growth Strategy ...

Swedish private equity firm EQT AB is launching a health-care growth strategy, broadening its offering to cater to companies in every stage of their development. The new vertical will focus on scaling ...

Mabtech, a holding company for China mAB biotechs, has in-licensed four monoclonal antibodies to San Diego-based Sorrento Therapeutics ($SRNE) with all of the ...

Sorrento Therapeutics, Inc., a clinical stage oncology company developing new treatments for cancer and associated pain, has entered into an exclusive licensing agreement to develop and commercialise ...

The new EQT Healthcare Growth Strategy builds on EQT's 30-year healthcare track record and will focus on scaling innovative, fast-growing healthcare companies to help deliver positive outcomes across ...

Article ‘Count’ and ‘Share’ for Mabtech AB based on listed parameters only. According to the parameters selected above, there are no articles from Mabtech AB from 1 July 2023 - 30 June 2024.